Company profile: Diaceutics
1.1 - Company Overview
Company description
- Provider of analytics, software, services and consulting that help pharmaceutical companies integrate diagnostic testing into treatment pathways, offering DXRX – The Diagnostic Network for collaboration and global real-world testing data, DXRX Data Solutions, DXRX Marketplace, DXRX Signal for testing behavior alerts, and insights via DXRX Physician Mapping and DXRX Lab Mapping.
Products and services
- DXRX Data Solutions: Pipeline-based access to diagnostic testing data from a network of laboratories, offering connected data pipelines to pharmaceutical teams via laboratory networks
- DXRX Marketplace: A precision-medicine-focused platform where stakeholders collaborate on diagnostics, enabling coordinated engagement among laboratories, diagnostic companies, and pharma partners through a dedicated marketplace format
- DXRX - The Diagnostic Network: A global-scale platform enabling collaboration across laboratory, diagnostic, and pharma stakeholders, delivering access to real-world diagnostic testing data globally to facilitate coordinated diagnostics collaboration
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Diaceutics
ZenBio
HQ: United States
Website
- Description: Provider of human cell-based research products and contract research services, including preadipocytes and adipocytes for drug screening and development; cell-based assay development and custom consultations; individualized cell-based or biochemical screening programs; cell characterization and molecular biology services; and ready-to-use visceral preadipocyte and adipocyte media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZenBio company profile →
Clinvest Research
HQ: United States
Website
- Description: Provider of clinical research services conducting clinical trials for headache and migraine, arthritis and joint pain, diabetes and weight management, and vaccines (flu, RSV, COVID). Partners with pharmaceutical companies to study and develop new treatments and health strategies, providing participants access to new treatments before they are widely available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinvest Research company profile →
Appletree CI
HQ: Switzerland
Website
- Description: Provider of specialized CRO and CSO services in ophthalmology and medical device investigations, offering global regulatory affairs and end-to-end clinical development solutions, flexible functional service outsourcing, real-world evidence and virtual studies, advisory and talent support, and strategic resourcing across 11 European nations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Appletree CI company profile →
ePatientFinder
HQ: United States
Website
- Description: Provider of an online platform that assists physicians to connect with their patients and obtain information on treatment options, using analytics to connect patients with cutting-edge treatments recently approved by the FDA or in clinical trials, and a network of primary care and specialty physicians to discover, learn about, and discuss novel treatment options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ePatientFinder company profile →
Cerbios
HQ: Switzerland
Website
- Description: Provider of chemical and biological active pharmaceutical ingredients (APIs), including high-potency APIs (HPAPIs) and antibody-drug conjugates (ADCs), with manufacturing and development capabilities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerbios company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Diaceutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Diaceutics
2.2 - Growth funds investing in similar companies to Diaceutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Diaceutics
4.2 - Public trading comparable groups for Diaceutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →